Author
Listed:
- Lorraine Regina Y. Co, MD
(Department of Anesthesiology, Amang Rodriguez Memorial Medical Center)
- Arlyn B. Napeñas
(Department of Anesthesiology, Amang Rodriguez Memorial Medical CenterDepartment of Anesthesiology, Amang Rodriguez Memorial Medical Center)
- Kate R. Wad-asen MD
(Department of Anesthesiology, Amang Rodriguez Memorial Medical Center)
Abstract
This retrospective observational study investigated the factors influencing neuromuscular blocking agent (NMBA) reversal agent use at Amang Rodriguez Memorial Medical Center (ARMMC) from June to December 2023. NMBAs facilitate endotracheal intubation, but reversal agents like Sugammadex and Neostigmine are used to prevent complications such as residual neuromuscular blockade. Objectives. This study aimed to determine the prevalence of reversal agent use and identify clinico-demographic characteristics affecting Sugammadex and Neostigmine administration. Data was collected via total enumeration sampling and chart review of 294 patients who underwent general anesthesia. The study examined variables including age, sex, BMI, comorbidities, ASA classification, and the specific muscle relaxant and reversal agent used. Statistical analysis involved descriptive statistics, Chi-square tests, and multivariate logistic regression. Results showed that Sugammadex was used in 69.4% of reversals. Significant associations were found between age and reversal agent choice, with Sugammadex favored in children (p
Suggested Citation
Lorraine Regina Y. Co, MD & Arlyn B. Napeñas & Kate R. Wad-asen MD, 2025.
"Association of Clinico-demographic Characteristics in the Use of Muscle Relaxant Reversal Agents in a Tertiary Hospital in the Philippines,"
International Journal of Research and Scientific Innovation, International Journal of Research and Scientific Innovation (IJRSI), vol. 12(9), pages 3408-3422, August.
Handle:
RePEc:bjc:journl:v:12:y:2025:i:9:p:3408-3422
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:bjc:journl:v:12:y:2025:i:9:p:3408-3422. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Dr. Renu Malsaria (email available below). General contact details of provider: https://rsisinternational.org/journals/ijrsi/ .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.